RxDoctor Payments Data

Mark Dotson

Podiatrist · Fort Smith, ARNPI 1689642019

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for podiatrist clinicians in AR, where the typical reported total is $1,089.

$1,067in general payments, 2019–2025

Across 46 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$175
  • AbbVie$138
  • Smith+Nephew$102
  • Kowa Pharmaceuticals America, Inc.$92
  • Amgen$90
  • Averitas Pharma Inc.$81
  • plus $389 from 13 others

What the payments were for

  • Food & beverage$1,067100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,067 in reported general payments places this provider in the 45th percentile of 35 podiatrist providers in Arkansas.

See all podiatrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$101,805
Medicare patients
395
Services billed
5,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin25$1,317
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha55$957
Ammonium Lactate44$794
Terbinafine Hcl82$574
Methylprednisolone40$351
Duloxetine Hcl22$235
Gabapentin30$204
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim46$185
Meloxicam51$128
ClopidogrelClopidogrel Bisulfate11$66

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →